Replimune Group, Inc.(REPL)内部人交易:高管与董事近期交易
过去 18 个月,共有 8 位内部人为 Replimune Group, Inc.(REPL)报告了 39 笔 Form 4 交易(最近一笔 2026-11-18)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-18 | Hill Emily Luisa | Chief Financial Officer | 卖出 | 14,709 | $317,714 |
| 2026-11-18 | Patel Sushil | Chief Executive Officer | 卖出 | 49,026 | $1.1M |
| 2026-11-18 | Xynos Konstantinos | Chief Medical Officer | 卖出 | 16,198 | $349,877 |
| 2026-11-18 | Schwendenman Andrew | Chief Accounting Officer | 卖出 | 2,148 | $46,397 |
| 2026-11-10 | SLATTERY JOSEPH P | 董事 | 卖出 | 5,200 | $113,360 |
| 2026-11-03 | Dhingra Kapil | 董事 | 买入 | 43,169 | $75,546 |
| 2026-11-03 | Dhingra Kapil | 董事 | 卖出 | 21,500 | $408,500 |
| 2026-08-24 | Astley-Sparke Philip | 董事 | 卖出 | 50,000 | $0 |
| 2026-08-19 | Hill Emily Luisa | Chief Financial Officer | 卖出 | 9,256 | $132,176 |
| 2026-08-12 | Xynos Konstantinos | Chief Medical Officer | 卖出 | 11,447 | $148,468 |
| 2026-08-12 | Patel Sushil | Chief Executive Officer | 卖出 | 39,341 | $510,253 |
| 2026-08-12 | Hill Emily Luisa | Chief Financial Officer | 卖出 | 11,448 | $148,481 |
| 2026-08-12 | Schwendenman Andrew | Chief Accounting Officer | 卖出 | 7,632 | $98,987 |
| 2026-06-03 | Sarchi Christopher | Chief Commercial Officer | 卖出 | 12,000 | $110,880 |
| 2026-05-20 | Hill Emily Luisa | Chief Financial Officer | 卖出 | 7,812 | $39,685 |
| 2026-05-20 | Patel Sushil | Chief Executive Officer | 卖出 | 37,324 | $189,606 |
| 2026-05-20 | Xynos Konstantinos | Chief Medical Officer | 卖出 | 14,023 | $71,237 |
| 2026-05-20 | Sarchi Christopher | Chief Commercial Officer | 卖出 | 8,626 | $43,820 |
| 2026-05-20 | Astley-Sparke Philip | 董事 | 卖出 | 17,657 | $89,698 |
| 2026-05-20 | Schwendenman Andrew | Chief Accounting Officer | 卖出 | 7,894 | $40,102 |
| 2026-04-07 | Sarchi Christopher | Chief Commercial Officer | 买入 | 50,000 | $0 |
| 2026-04-07 | Astley-Sparke Philip | 董事 | 买入 | 50,000 | $0 |
| 2026-04-07 | Xynos Konstantinos | Chief Medical Officer | 买入 | 50,000 | $0 |
| 2026-04-07 | Hill Emily Luisa | Chief Financial Officer | 买入 | 50,000 | $0 |
| 2026-04-07 | Patel Sushil | Chief Executive Officer | 买入 | 251,240 | $0 |
来源:SEC Form 4 申报文件 · 截至 2026-11-18